01 1Natco Pharma
01 1SUMATRIPTAN SUCCINATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-16
Pay. Date : 2014-04-30
DMF Number : 16930
Submission : 2003-10-23
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUMATRIPTAN SUCCINATE, with a corresponding US DMF Number 16930.
Remarkably, this DMF maintains an Active status since its submission on October 23, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2014, and payment made on April 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
